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Abstract
This study evaluated whether the reduction of prefrontal cortex oxygenation (ScO2) during 
maximal exercise depends on the hyperventilation-induced hypocapnic attenuation of middle 
cerebral artery blood velocity (MCA Vmean).  Twelve endurance-trained males (age: 25 ± 3 years, 
height: 183 ± 8 cm, weight: 75 ± 9 kg; mean ± SD) performed in three separate laboratory visits, a 
maximal oxygen uptake (VO2max) test, an isocapnic (end-tidal CO2 tension (PetCO2) clamped at 
40 ± 1 mmHg), and an ambient air controlled-pace constant load high intensity ergometer cycling 
to exhaustion, while MCA Vmean (transcranial Doppler ultrasound) and ScO2 (NIRS) were 
determined. Duration of exercise (12 min 25 s ± 1 min 18 s) was matched by performing the 
isocapnic trial first. Pulmonary VO2 was 90 ± 6% vs. 93 ± 5% of the maximal value (P = 0.012) 
and PetCO2 40 ± 1 vs. 34 ± 4 mmHg (P < 0.05) during the isocapnic and control trials, 
respectively. During the isocapnic trial MCA Vmean increased by 16 ± 13% until clamping was 
applied and continued to increase (by 14 ± 28%; P = 0.017) until the end of exercise, while there 
was no significant change during the control trial (P = 0.071). In contrast, ScO2 decreased 
similarly in both trials (-3.2 ± 5.1% and -4.1 ± 9.6%; P < 0.001, isocapnic and control, 
respectively) at exhaustion. The reduction in prefrontal cortex oxygenation during maximal 
exercise does not depend solely on lowered cerebral blood flow as indicated by middle cerebral 
blood velocity.
Key words: middle cerebral artery blood velocity, cerebral oxygenation, end-tidal PCO2, 
controlled-pace exercise
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1. Introduction
Cerebral blood flow (CBF) is tightly coupled to cerebral metabolism with a "surplus" increase in 
flow reflected in the blood oxygenation level-dependent signal1 and in the near-infrared 
spectroscopy (NIRS) detected oxygenation.2 Low to moderate intensity dynamic whole body 
exercise elevates CBF as evaluated by 133Xe clearance,3,4 middle cerebral artery mean flow 
velocity (MCA Vmean),4,5,6 and evaluation of flow in the internal carotid and vertebral arteries.7 The 
increase in MCA Vmean  during low to moderate exercise is attributed, at least in part, to the initial 
increase in arterial carbon dioxide tension (PaCO2) in response to exercise metabolism. Yet, as 
exercise intensity progresses, MCA Vmean  is either plateuing, or reduced towards the resting value, 
dependent on the magnitude of hyperventilation-induced hypocapnia,3,4,8 that may reduce PaCO2 
to as low as ~29 mmHg.9 A similar response pattern is described for the NIRS determined frontal 
lobe oxygenation (ScO2) with an increase during low intensity exercise and then a gradual 
decrease when exercise intensity approaches a maximal level and exercise-induced hypocapnia 
develops.9 This parity in the responses of ScO2 and MCA Vmean during low to moderate exercise 
has been linked to the neuronal activation2, while as exercise intensity progresses humoral factors 
(f.x., hyperventilation-induced hypocapnia) are suggested to have a more prominent role.10
The relationship between ScO2 and MCA Vmean and its relevance for exercise 
performance has been addressed by preventing the exercise hyperventilation-induced hypocapnic 
reduction in CBF with CO2 supplementation during incremental11-14 and time trial cycling 
exercise15. CO2 supplementation enhances cerebral oxygen delivery without affecting systemic 
oxygen delivery and thus, allows the exclusive evaluation of the effect of cerebral oxygenation on 
exercise performance. However, even though clamping the end-tidal PCO2 (PetCO2) increased 
MCA Vmean and attenuated the decrease in ScO2, exercise performance was not enhanced.11,13,14 
During both maximal incremental exercise12 and time trial cycling exercise at ~65-85% of 
maximal oxygen uptake (VO2max)15 the increase in MCA Vmean, besides not enhancing exercise 
performance, did not attenuate the decrease in ScO2, i.e. suggesting a seemingly mismatch 
between cerebral activation and cerebral oxygenation16. Since controlled-pace exercise may 
impose higher metabolic demands than self-paced exercise,17 it was considered that increased 
afferent stimulation during controlled-pace exercise may impose an even greater metabolic 
demand on the prefrontal cortex18 than incremental and self-paced exercise and thus provoke 
higher cerebral (de)oxygenation.19 The cerebral (de)oxygenation and MCA Vmean responses during A
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controlled-pace maximal exercise have not being evaluated and we hypothesized that during 
controlled-pace maximal exercise, the parity beetween ScO2 and MCA Vmean would be challenged. 
In order to test this hypothesis we evaluated ScO2 and MCA Vmean during controlled-
pace high-intensity (90-95% VO2max) combined with a final all-out sprint to exhaustion 
simulating, e.g. short cycling time trials.20 Considering that hyperventilation-induced hypocapnia 
during high intensity exercise attenuates MCA Vmean, we clamped PetCO2 at 40 mmHg with CO2 
supplementation. In order to evaluate whether a similar effort was required with and without CO2 
supplementation, we assessed motor activation of the inspiratory muscles by measuring maximal 
inspiratory pressure (MIP) before and after exercise, as has been evaluated in other skeletal muscle 
groups following exhaustive leg (e.g.21) and handgrip exercise.22 During high intensity whole body 
endurance exercise large ventilatory demand may provoke respiratory fatigue even in endurance 
athletes.23 
2. Methods
2.1. Subjects and study design
Thirteen healthy endurance trained males (VO2max: 62 ± 6 ml/kg/min), following informed 
written and oral consent, volunteered to participate in the study as approved by the Ethical 
Committee of Copenhagen (H-16035280) and confirming to the Declaration of Helsinki, except 
for registration in a database. Sample size estimation was based on ScO2 during exercise with and 
without a CO2 clamp15 and power of 0.90 with an α of 0.05. One subject was excluded from 
analysis due to inadequate Doppler signal during exercise, thus results from 12 subjects are 
reported (age 25.3 ± 2.7 years, height: 183 ± 8 cm, body mass: 75 ± 9 kg).
The subjects visited the laboratory at the same time of the day on three occasions after having 
refrained from caffeine, alcohol, and strenuous exercise for at least 24 h. At the first visit, the 
subjects were familiarized with inhalation of CO2-enriched air and then performed incremental 
cycling (Monark 839E, Varberg, Sweden) to exhaustion for determination of VO2max. Following a 
10 min warm-up at 100 W and 2 min recovery, the subjects cycled at 200 W with the workload 
increased by 40 W every 2 min until exhaustion. The maximum workload was calculated as Wmax 
= Wcompleted + 40 W * (t/120), where Wcompleted is the workload of the last completed step and t the 
seconds at the uncompleted step. On the two following visits, constant-load (~90-95% VO2max) 
cycling to exhaustion was carried out while breathing either ambient air (control trial), or ambient 
air and a mixture of ambient and CO2-enriched air (10% CO2, 21% O2, 69% N2; isocapnic trial). A
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The workload during the two trials was determined based on that associated with 90% VO2max 
during the VO2max test. The targeted workload was maintained for 10-12 min, depending on the 
subject’s capacity, and when the subjects approached fatigue they were exposed to a ~20% 
increase in power output in an all-out sprint to exhaustion. The rationale for the final all-out sprint 
was both to maximize cerebral metabolic demand and, to simulate the finishing sprint of most 
cycling races. The subjects received visual feedback of exercise duration and encouragement to 
provide an all-out effort, while the pedaling frequency was freely chosen. During the isocapnic 
trial, PetCO2 was monitored visually and maintained at 40 mmHg by manually administering the 
CO2-enriched air to an open-ended reservoir that served as mixing chamber with ambient air (24, 
Fig.1, Clamp). To partially control for the potential respiratory acidosis and increased ventilatory 
drive induced with CO2 supplementation, we clamped PetCO2 only when subjects began 
developing hyperventilation-induced hypocapnia (i.e. PetCO2 falling below 40 mmHg). In a pilot 
study, PetCO2 could be maintained within ± 1.7 mmHg (reliability, coefficient of variation < 4%). 
Considering that supplementation of CO2 during the isocapnic trial could increase ventilation (VE) 
and thus, possibly limit exercise performance,11 the isocapnic trial was carried out first so that the 
total work performed could be matched in the control trial. Matching the work performed in the 
two trials allows for a comparison of the cerebrovascular responses to assumed comparable 
cerebral neural stimulation while the humoral stimulus from the hyperventilation-induced 
hypocapnia is diminished.
2.2. Cerebral blood velocity and oxygenation
Trans-cranial Doppler ultrasound (TCD; 2 MHz probe; Multidop X; DWL, Sipplingen, Germany) 
determined MCA Vmean and used as an index of CBF, since changes in MCA Vmean reflect those of 
CBF during dynamic exercise.25,26 MCA Vmean was the mean velocity of the time-averaged 
maximal velocity over the cardiac cycle derived from the envelope of the maximum frequencies 
from the Doppler spectra. MCA was located unilaterally by insonation through the temporal 
ultrasound window and the position with the highest signal to noise ratio (depth 48-60 mm) 
marked. The probe was fixed to a headband with adhesive sonography gel and data sampled at 100 
Hz with an AD converter (Chart v5.2 and Powerlab; ADInstruments, Bella Vista, NSW, Australia) 
and analysed offline (Labchart ver. 7.3, AD Instruments, Colorado Springs, CO, USA). ScO2 was 
evaluated using NIRS (INVOS 5100C, Somanetics, Troy, MI, USA) with a sampling frequency of 
0.3 Hz. The optode (3 and 4 cm emitter-detector separation, wavelength 730 and 808 nm) was 
placed over the prefrontal cortical area between Fp1 and F3, or Fp2 and F4, according to the A
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landmarks of the 10-20 system to avoid influence from the frontal and sagittal sinus26 and 
ipsilateral to the Doppler probe. Considering the wide intra-individual baseline variability 
(coefficient of variation for absolute baseline values of approximately 10%, 28) of cerebral 
oximetry, we used NIRS data as a trend monitor. It was considered that there are no differences 
between the two hemispheres during cycling9,13 and the same placement of the TCD probe and 
NIRS optode was applied in both trials. 
2.3. Ventilatory variables
PetCO2, VE, respiration frequency (RF), tidal volume (VT), CO2 production (VCO2), VO2, and 
ventilatory equivalents for CO2 (VE/VCO2) and O2 (VE/VO2) were measured breath-by-breath by a 
metabolic cart (Quark CPET, Cosmed, Rome, Italy). Calibration before each trial was according to 
the manufactures guidelines and VO2max was taken as the average VO2 over 30 breaths.13 
2.4. Cardiovascular variables
Heart rate (HR) was measured with a belt (Garmin, Olathe, Kansas, USA) and mean arterial 
pressure (MAP) and cardiac output (CO) using finger plethysmography with a cuff placed at the 
middle phalanx of the third finger connected to a non-invasive monitor (Nexfin: BMEYE, Model 
2, Amsterdam, The Netherlands). Values were corrected for the influence of hydrostatic pressure 
with a height sensor fixed at the estimated level of the heart. In case of inadequate signal, the 
finger was warmed.29 
2.5. Blood sampling  
PaCO2 and arterial oxygen saturation (SaO2) were evaluated in two subjects by samples drawn 
from a line in the right brachial artery under local anaesthesia (lidocaine 2%). The blood samples 
were drawn at rest and every 2 min during both exercise trials with the last sample immediately 
before and after (n = 1) exhaustion and analyzed immediately (ABL 800 FLEX Radiometer, 
Copenhagen, Denmark).
2.6. Motor activation
MIP was evaluated by a maximal voluntary inspiratory maneuver (Mueller) using a handheld 
mouth pressure meter (POWERBreathe KH1, Warwickshire, England). The subjects were 
familiarized with the  maneuver by performing an inspiratory warm up that increases reliability.30  
Each maneuver was initiated from residual volume (RV) by exhaling slowly until the subjects felt 
their lungs “empty” and they were then encouraged to inhale with a maximal effort for 2-3 s. 
Before the exercise trials, the subjects performed the inspiratory warm up and subsequently 3 MIP 
maneuvers with 1 min recovery between efforts and the most negative pressure over 1 s noted as A
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MIPpre. A pilot study indicated that the mean between-day CV and within-day CV for MIPpre was 
3.5% and 4.5%, respectively. Immediately after completion of the exercise trials, another MIP was 
determined and noted as MIPpost. 
2.7. Statistical methods
All variables were recorded continuously, analyzed with a custom-made program in MatLab 
R2016b (MathWorks, Natick, Massachusetts, USA), and presented as mean ± SD. In order to 
account for the different sampling frequencies between the NIRS and TDC devices, NIRS data 
were interpolated to the same length as the TCD data (100 Hz), averaged over 15 s and time 
aligned according to the conditions established during the trials: 1) immediately before the warm-
up (Rest), 2) time of PetCO2 clamping during the isocapnic trial (Clamp) and time that PetCO2 
dropped below 40 mmHg during the control trial (No-clamp), and 3) in the last 15 s of intense 
exercise (end-exercise). Variables are reported as absolute values, and for MCA Vmean and ScO2, 
also as percentage of values at rest. Comparisons of data at Clamp vs. end-exercise during the 
isocapnic trial, at No-clamp vs. end-exercise during the control trial, and between trials, allowed 
for evaluation of the effect of high intensity exercise to exhaustion on MCA Vmean and ScO2. A 
two-way ANOVA for repeated-measurements was used to evaluate differences between (control 
and isocapnic) and within (Noclamp/Clamp and at end-exercise) trials with Bonferroni corrected 
p-values according to the number of comparisons between and within trials. Similarly, differences 
between MIPpre and MIPpost, and between baseline values were tested with paired and independent 
Student’s t-tests. Association between variables was evaluated with Pearson's correlation 
coefficient. The statistical significance level was set to P < 0.05 and analysis performed using 
SPSS Statistics 24 (IBM, Armonk, New York, USA).
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3. Results
VO2max was 62 ± 6 ml/kg/min and Wmax 371 ± 43 W. Although, the two exercise trials were 
matched for duration and power output (12 min 25 s ± 1 min 18 s and 286 ± 33 W, respectively) 
there was a small difference in % VO2max between the isocapnic (90 ± 6%) and control trial (93 ± 
5%; P = 0.012, Table 1). The duration of the controlled-pace and all-out sprint stages was 11 min 
28 s ± 54 s and 48 s ± 28 s, respectively.
3.1. Respiratory variables
During the isocapnic trial, PetCO2 was maintained at 40 ± 1 mmHg from Clamp until end end-
exercise, whereas during the control trial PetCO2 decreased from 40 ± 1 at No-clamp to 34 ± 4 
mmHg at end-exercise (P < 0.001, Fig. 2C). One subject had a high resting PetCO2 (44 mmHg) 
and thus the targeted value during the isocapnic trial was adjusted accordingly. There was no 
difference between the two trials at rest and Clamp or No-clamp (40 ± 2 and 40 ± 1 mmHg). 
During both trials, VE increased from Clamp, or No-clamp, to end-exercise (129 ± 12 to 176 ± 19, 
isocapnia and 125 ± 11 to 167 ± 18 l/min, control; P < 0.001, respectively) but there were no 
differences in VE between trials at any time. 
There was no change in VO2 from Clamp to end-exercise during the isocapnic trial (4.24 ± 0.4 to 
4.32 ± 0.4 l/min), while VO2 increased from No-clamp to end-exercise during the control trial 
(4.28 ± 0.4 to 4.53 ± 0.4 l/min; P = 0.015), but there were no significant differences between the 
two trials at any time. VCO2 increased during both trials from Clamp or No-clamp to end-exercise 
(4.65 ± 0.4 to 5.28 ± 0.8 and 4.55 ± 0.4 to 4.88 ± 0.6 l/min; P = 0.018 and 0.028, respectively). At 
end-exercise VCO2 was higher during the isocapnic compared with the control trial (5.28 ± 0.8 vs. 
4.88 ± 0.6 l/min; P = 0.03).
VE/VO2 increased from Clamp, or No-clamp to end-exercise during both trials (isocapnic 30.6 ± 
2.3 to 41.0 ± 5.7; control 29.4 ± 1.9 to 37.0 ± 4.2; P < 0.001). VE/VO2 was higher at Clamp and 
No-clamp during the isocapnic compared with the control trial (30.6 ± 2.3 vs. 29.4 ± 1.9; P = 
0.007) and at end-exercise (41.0 ± 5.7 vs. 37.0 ± 4.2; P < 0.001, respectively), Similarly, VE/VCO2 
increased equally from Clamp or No-clamp to end-exercise (isocapnic 27.8 ± 1.4 to 33.6 ± 3.7; 
control 27.6 ± 1.1 to 34.4 ± 3.7; P < 0.001) with no difference between trials.
3.2. Cardiovascular variables
There was no difference in HR, MAP (n = 11, no evaluation at rest for one subject), or CO (n = 4) 
at any time.A
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3.3. Blood gas variables 
The arterial blood samples (n = 2) confirmed elevation of PaCO2 during the isocapnic compared to 
the control trial. The correlation between PetCO2 and PaCO2 was highest in the control trial (r = 
0.80 vs. r = 0.60). 
3.4. Cerebrovascular variables
During the isocapnic trial MCA Vmean increased by 16 ± 13% until the time that clamping was 
applied and continued to increase (by 14 ± 28%; P = 0.017, Table 1) until the end of exercise, 
while MCA Vmean did not change significantly during the control trial (P = 0.071, Fig. 2A). In 
contrast to the disparity in MCA Vmean response, ScO2 (n = 11) decreased similarly from Clamp, or 
No-clamp to end-exercise (-3.2 ± 5.1% and -4.1 ± 9.5%, isocapnic and control, respectively; P < 
0.001) during both trials, while there was no difference between trials (Table 1, Fig. 2B). 
3.5. Motor activation
MIP decreased by 12% following the isocapnic (P < 0.001) and 7% following the control trials (P 
= 0.025) with no difference between the two trials.
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4. Discussion
This study evaluated the relationship between ScO2 and CBF during controlled-pace high-intensity 
exercise to exhaustion and found that clamping of PetCO2 elevated MCA Vmean but did not prevent 
the reduction in ScO2 established at exhaustion following comparable efforts, as evaluated by the 
similar decline in inspiratory muscle strength during the isocapnic and control trials. The finding 
of a mismatch between changes in ScO2 and MCA Vmean is in aggreement with observations 
during maximal incremental exercise12 and and self-paced cycling performance.15 Our hypothesis 
that the parity between ScO2 and MCA Vmean would be challenged during controlled pace exercise 
was confirmed. However, despite the assumed elevated cerebral metabolic demands during 
controlled pace exercise, cerebral de(oxygenation) at the end of both trials was comparable with 
previous reports,12,15, even in hypoxia,13 and MCA Vmean at the end of the isocapnic trial was ~15% 
lower than previously reported.12 Our data suggest physiological “uncoupling” between prefrontal 
cortex oxygenation and CBF during high-intensity exercise to exhaustion.
At exhaustion in the control trial, PetCO2 fell below the resting value, while MCA 
Vmean did not change in parallel, providing support to reports questioning the relationship between 
MCA Vmean and PetCO2 during high intensity exercise.31,12 In addition, during the isocapnic trial, 
when PetCO2 was clamped, MCA Vmean continued to increase until exhaustion (by 14%), rather 
than being maintained, as would be expected if PaCO2 was the sole determinant of CBF. Taken 
together, these findings indicate that while PaCO2 is a critical regulator, it is not the only factor 
affecting cerebral perfusion during intense exercise, in confirmation of findings during 
submaximal32 and incremental exercise.12 The continuous increase in MCA Vmean during the 
isocapnic trial, despite a similar MAP, CO and SaO2  in the two trials (Table 1), suggests that this 
progressive rise in cerebral blood velocity cannot be accounted by changes in perfusion pressure, 
or circulating systemic stimuli (such as arterial hypoxemia). The increase in MCA Vmean is likely 
driven by increased neural activity and the cerebral metabolic demand associated with high 
intensity exhaustive exercise. Considering that the cerebral metabolic demands due to neural 
activity were similar between the two trials (suggested by the matched workload and time to 
exhaustion) it can be inferred that the regional cerebral blood velocity response to exercise is 
increasing linearly with exercise intensity but that hyperventilation-induced hypocapnia imposes 
cerebral vasoconstriction and is masking this response as illustrated in the control trial. 
Dissociation between oxygenation and CBF has been indicated from a weak 
association between the two variables after exercise-induced hyperventilation sets in.31 A
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Dissociation between cerebral perfusion and ScO2 revealed with PetCO2 clamping, alluding to a 
seemingly surplus in cerebral perfusion, may be reflective of the structure of the cerebral 
vasculature. Cerebral capillaries are not different from those in other vascular beds, but while the 
capillaries within skeletal muscle are positioned in direct contact to the muscles cells, within the 
brain there is the blood-brain barrier between the capillaries and the neurons making the diffusion 
distance for O2 critical when cerebral activity is elevated. Also, while skeletal muscles increase 
capillary recruitment in order to establish the O2 gradient for adequate O2 diffusion, the lack of 
capillary recruitment in the brain may necessitate an increase in CBF for that purpose.26 An 
alternative explanation for the lack of enhancement of prefrontal cortex oxygenation despite the 
increased MCA Vmean could be because middle cerebral artery flow is not all directed to the 
prefrontal cortex but also to the lateral surface of the temporal and parietal lobes. Support for such 
cerebral blood flow redistribution and variable proportional blood flow contribution of cerebral 
arteries is provided by the attenuation of flow in the internal carotid but not in the vertebral artery 
during graded dynamic exercise. 7 
A limitation is that CBF was assessed by determination of MCA Vmean that measures 
flow velocity rather than volume flow33 and it is critical for the validity of TCD in reporting flow 
changes that the vessel diameter remains constant. Even though the MCA diameter increases with 
marked elevation in PetCO2, it remains stable within ± 7.5 mmHg of the resting value,34 which is 
within the limits observed in the present study (PetCO2 at Clamp and No-clamp: 40 ± 2 and 40 ± 1 
mmHg, and at end exercise: 40 ± 1 vs. 34 ± 4 mmHg, isocapnic and control trial, respectively). 
Another consideration is vasoconstriction of large cerebral arteries during exercise-induced 
sympathetic activation.35 However, a strength of this study is that workload was matched and, the 
inspiratory muscle deficit developed in the two trials was similar, suggesting that the 
sympathoexcitation elicited was also similar.  Another consideration with the sequential execution 
of the two trials is a possible confounding influence of an order effect. However, since the purpose 
of the study was to evaluate the relationship between ScO2 and MCA Vmean during maximal 
controlled-pace exercise and not cycling performance per se, the order of the trials is not 
considered to have had influenced the cerebrovascular response.
During exercise with a small muscle mass (handgrip) muscle fatigue has been related 
to reduced cerebral oxygenation22 and thus, it is considered that reduced prefrontal cortex 
oxygenation rather than CBF per se could be important for development of fatigue also during 
whole body exercise. A decline in frontal lobe cerebral oxygenation from submaximal to maximal A
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exercise intensity is a consistent finding.36 Prefrontal cortex oxygenation is a regional 
measurement and may not be reflective of the global value, although that is debated.36 It can be 
argued that evaluation of motor cortex oxygenation would be more relevant to exercise, but there 
is agreement between oxygenation recorded by NIRS from the prefrontal cortex and a calculation 
of cerebral capillary oxygenation.22 Furthermore, during maximal cycling exercise changes in 
NIRS-determined cortical oxygenation are similar in the prefrontal, premotor and motor regions37 
and thus, are probably indicative of elevated oxygen demands, as shown by the increased cerebral 
metabolic rate for oxygen.38 It is also considered that assessment of cerebral oxygenation by NIRS 
may be affected by changes in skin blood flow39 that would be elevated by the end of exercise as 
body temperature increases. The ambient temperature and relative humidity during the two trials 
were similar (23 ± 1 C°, 23 ± 4% and 23 ±1 C°, 26 ± 4%, isocapnic and control, respectively), 
indicating that the possible influence of skin blood flow was similar in the two trials, and thus it is 
not expected to affect our interpretation. Nevertheless, even if we consider that skin blood flow 
may have affected our ScO2 values such possibility would only strengthen our argument for 
dissociation between ScO2 and MCA Vmean because that would mean that the extend of the 
dissociation can be even larger than our observation. Another consideration is that the ScO2 
provided by the NIRS device only reflects the relative change in the ratio of oxyhaemoglobin and 
total haemoglobin, begging the question whether there could have been a stronger association 
between MCA Vmean and total haemoglobin during the exercise trials. However, since the focus of 
the paper is the possible dissociation between cerebral blood flow and cerebral tissue oxygenation, 
the ScO2 measurement is useful for the evaluation. 
Even though we succeeded to clamp PetCO2 with very low variability, yet we 
clamped PetCO2 rather than the arterial PaCO2. The PetCO2 – PaCO2 gradient changes during 
exercise,40 and thus it should be taken into account that PetCO2 may not have reflected PaCO2, 
especially because CO2 supplementation can exert an independent effect of PetCO2 in 
overestimating PaCO2.41 However, even if we consider that the reported PetCO2 may overestimate 
PaCO2, alluding that hypocapnic vasoconstriction was not completely abolished, our interpretation 
of increased MCA Vmean during the isocapnic trial still holds. Blood data from albeit only 2 
subjects showed a high correlation between PetCO2 and PaCO2. In support, during high-intensity 
exercise PaCO2 and PetCO2 are similar when corrected for blood temperature.42 Supplementation 
of CO2 during the isocapnic trial could have exaggerated metabolic acidosis and, via the Bohr 
effect, provoked a rightward shift on the oxyhaemoglobin curve and thus decreased SaO2, which A
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might have contributed to the decrease in ScO2 from Clamp to end-exercise despite the increase in 
MCA Vmean. Yet, arterial oxygen saturation if anything, was higher during isocapnic compared to 
control (Table 1). 
5. Perspective
Even though exercise performance was not evaluated in the present study, the development of 
prefrontal cortex deoxygenation at exhaustion provides support to the postulate of cerebral 
deoxygenation as a limiting factor for exercise performance. The reduction of ScO2 during 
controlled-pace high-intensity exercise to exhaustion, while MCA Vmean is enhanced with CO2 
supplementation, argues for regional heterogeneity and compartmentalization of function and 
metabolism in the brain. It is suggested that the “seemingly” surplus in MCA Vmean is not all 
directed to the prefrontal cortex but also to the lateral surface of the temporal and parietal lobes. 
The all-out finishing sprint complicates precise coupling between cerebral blood flow and 
prefrontal cortex oxygenation, but a discrepancy between ScO2 and MCA Vmean.developed even 
during the controlled cycling stage. Also, it should be considered that cerebral blood flow during 
maximal exercise, rather than being regulated to deliver oxygen, could be regulated to maintain 
fuel availability (e.g., glucose and/or lactate delivery; 43). 
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Table. Variables at rest and during the control and isocapnic exercise trials 
Control trial                                               Isocapnic trial
Rest No-clamp End-exercise Rest            Clamp       End-exercise
Power, W  286 ± 33  343 ± 39  -  286 ± 33  343 ± 39
MCA Vmean, cm/s 65.0 ± 14.0  71.0 ± 22.2  67.0 ± 23.4  63.32 ± 11.5  74.0 ± 15.6  82.9 ± 23.6*†
ScO2, % 74.5 ± 7.6  75.9 ± 9.8  71.8 ± 9.5 *  72.2 ± 6.7  73.0 ± 5.3  69.8 ± 4.9*
PetCO2, mmHg 37 ± 2  40 ± 1  34 ± 4*  37 ± 2  40 ± 2  40 ± 1†
VE, l/min 12.9 ± 3.7  125.4 ± 10.8  167.1 ± 18.3*  13.7 ± 2.9  129.1 ± 11.6  175.7 ± 19.4*
RF, breaths/min 15 ± 3  39 ± 7  59 ± 11*  14 ± 4  42 ± 8†  62 ± 9*
VT, l/breath 0.9 ± 0.3  3.3 ± 0.6  2.9 ± 0.6*  1.1 ± 0.6  3.2 ± 0.6  2.9 ± 0.7*
SaO2, % 97.8 ± 0.6 91.6 ± 0.4 91.5 ± 0.3 97.5 ± 0.4 93.2 ± 0.4 93.4 ± 0.2
VO2, l/min 0.51 ± 0.2  4.28 ± 0.5  4.53 ± 0.4  0.51 ± 0.1  4.24 ± 0.4  4.31 ± 0.5
VCO2, ml/min 0.42 ± 0.1  4.55 ± 0.4  4.88 ± 0.6  4.44 ± 0.8  4.65 ± 0.4  5.28 ± 0.8†
VE/VO2 26.4 ± 2.2  2.4 ± 1.9  37.0 ± 4.2*  27.4 ± 3.5  30.6 ± 2.3†  41.0 ± 5.7*†
VE/VCO2 31.7 ± 2.7  27.6 ± 1.1  34.4 ± 3.7*  31.6 ± 2.9  27.8 ± 1.4  33.6 ± 3.7*
MAP, mmHg 100 ± 7  123 ± 10  126 ± 22  99 ± 14  120 ± 17  117 ± 24
CO, l/min 5.7 ± 0.7  20.9 ± 0.7  22.2 ± 2.9  5.7 ± 2.7  20.7 ± 2.7  23.4 ± 2.4
HR, bpm 71 ± 14  177 ± 8  187 ± 4  67 ± 10  177 ± 8  187 ± 5
MIP, cm H2O 159 ± 24 - - 148 ± 24* 163 ± 27 - - 144 ± 21*
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
Power, power output; MCA Vmean, mean cerebral blood flow velocity in the middle cerebral artery; ScO2, cerebral oxygenation; PetCO2, end-tidal 
carbon dioxide pressure; VE, ventilation; RF, respiratory frequency; VT, tidal volume; SaO2, arterial oxygen saturation; VO2, oxygen consumption; 
VCO2, carbon dioxide output; VE/VO2, ventilatory equivalent for oxygen; VE/VCO2, ventilatory equivalent for carbon dioxide; MAP, mean arterial 
pressure; CO, cardiac output; HR, heart rate; MIP, maximal inspiratory pressure. Values are means ± SD; n = 12 subjects, except ScO2 and MAP n = 
11, CO n = 4 and SaO2 n = 2; *, difference from No-clamp or Clamp to end-exercise; †, difference between isocapnic and control trials (P < 0.05). 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
Figure legends
Figure 1. End-tidal PCO2 clamp. The operator visually monitors breath-by-breath PetCO2 and 
manually adds CO2-enriched air to an open-ended inspiratory reservoir to maintain PetCO2 
(Adopted from Ref.24).
Figure 2. Cerebrovascular and respiratory variables at rest and during the isocapnic and control 
exercise trials. A, MCA Vmean, middle cerebral artery mean blood flow velocity. B, ScO2, 
cerebral oxygenation. C, PetCO2, end tidal carbon dioxide pressure. Because Clamp, No-
clamp and exhaustion occurred at different times for each subject exercise time was 
expressed in iso-times. Values are means ± SD; *, difference from No-clamp or Clamp to 
end-exercise; †, difference between isocapnic and control exercise trials, (n = 12, P < 0.05). 
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